ALKBH5 Promotes Breast Cancer Stemness Through Regulating Wnt/β-Catenin Signaling

Kailin Wang,1,2 Kaiting Wang1 1Institute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People’s Hospital, The Second Affiliated Hospital, School of Medicine, Southern University of Science and Technology, Shenzhen, 518112, People’s Republic of China; 2Breast Cancer Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510289, People’s Republic of ChinaCorrespondence: Kaiting Wang, Institute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People’s Hospital, The Second Affiliated Hospital, School of Medicine, Southern University of Science and Technology, Shenzhen, 518112, People’s Republic of China, Tel +86-0755-61238989, Email [email protected]: Breast cancer is the most prevalent disease and the fourth cause of cancer death among female globally. The N6-methyladenylate methylation (m6A) demethylase alpha-ketoglutarate-dependent dioxygenase alkB homolog 5 (ALKBH5) decreases modification of RNA, while its role in regulating breast cancer development remains unclear.Methods: ALKBH5-silenced breast cancer cell-line MCF-7 was constructed to investigate its functional impact. Cell proliferation, migration and invasion ability were evaluated by CCK8 and transwell assays under ALKBH5 inhibition. Spheroid formation and in vitro extreme limiting dilution analysis (ELDA) were performed to elucidate the effect of ALKBH5 deficiency on stemness of MCF-7 cells. The m6A modification level of CTNNB1 and the interaction of ALKBH5 and CTNNB1 were investigated by Methylated RNA immunoprecipitation (MeRIP) and RIP assay respectively.Results: Silencing ALKBH5 significantly suppressed MCF-7 cell proliferation, migration, and invasion abilities. Moreover, ALKBH5 depletion also diminished the stemness of breast cancer cells in vitro. Further investigation illustrated that ALKBH5 may regulate Wnt/β-catenin signaling via an m6A-dependant manner. Clinical data analysis demonstrated a strong positive relationship between ALKBH5 and β-catenin expression.Conclusion: This study establishes a link between ALKBH5 and cancer stemness in breast cancer, providing insights into the functional role of demethylase ALKBH5 in breast cancer progression.Keywords: N6-methyladenosine, (m6A), breast cancer, ALKBH5, stemness, CTNNB1

Publication Details

Journal
Dove Medical Press (Taylor and Francis Group)
Published
2025-06-06
Primary Topic
RNA modifications and cancer
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

ALKBH5 Promotes Breast Cancer Stemness Through Regulating Wnt/β-Catenin Signaling

Dove Medical Press (Taylor and Francis Group)
RNA modifications and cancer
article

ALKBH5 Promotes Breast Cancer Stemness Through Regulating Wnt/β-Catenin Signaling

article en

Abstract

Kailin Wang,1,2 Kaiting Wang1 1Institute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People’s Hospital, The Second Affiliated Hospital, School of Medicine, Southern University of Science and Technology, Shenzhen, 518112, People’s Republic of China; 2Breast Cancer Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510289, People’s Republic of ChinaCorrespondence: Kaiting Wang, Institute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People’s Hospital, The Second Affiliated Hospital, School of Medicine, Southern University of Science and Technology, Shenzhen, 518112, People’s Republic of China, Tel +86-0755-61238989, Email [email protected]: Breast cancer is the most prevalent disease and the fourth cause of cancer death among female globally. The N6-methyladenylate methylation (m6A) demethylase alpha-ketoglutarate-dependent dioxygenase alkB homolog 5 (ALKBH5) decreases modification of RNA, while its role in regulating breast cancer development remains unclear.Methods: ALKBH5-silenced breast cancer cell-line MCF-7 was constructed to investigate its functional impact. Cell proliferation, migration and invasion ability were evaluated by CCK8 and transwell assays under ALKBH5 inhibition. Spheroid formation and in vitro extreme limiting dilution analysis (ELDA) were performed to elucidate the effect of ALKBH5 deficiency on stemness of MCF-7 cells. The m6A modification level of CTNNB1 and the interaction of ALKBH5 and CTNNB1 were investigated by Methylated RNA immunoprecipitation (MeRIP) and RIP assay respectively.Results: Silencing ALKBH5 significantly suppressed MCF-7 cell proliferation, migration, and invasion abilities. Moreover, ALKBH5 depletion also diminished the stemness of breast cancer cells in vitro. Further investigation illustrated that ALKBH5 may regulate Wnt/β-catenin signaling via an m6A-dependant manner. Clinical data analysis demonstrated a strong positive relationship between ALKBH5 and β-catenin expression.Conclusion: This study establishes a link between ALKBH5 and cancer stemness in breast cancer, providing insights into the functional role of demethylase ALKBH5 in breast cancer progression.Keywords: N6-methyladenosine, (m6A), breast cancer, ALKBH5, stemness, CTNNB1

Dove Medical Press (Taylor and Francis Group)
Good health and well-being
Openalex Percentile: Top 51%
RNA modifications and cancer
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

ALKBH5 Promotes Breast Cancer Stemness Through Regulating Wnt/β-Catenin Signaling · Dove Medical Press (Taylor and Francis Group) (2025) | TGRS Research Map | TGRS